| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $18.7M | +221.4% |
| SG&A Expense | $17.7M | +125.7% |
| Operating Income | -$30.2M | +13.1% |
| Interest Expense | $749K | -17.3% |
| Pre-tax Income | -$26.6M | +29.4% |
| Income Tax | $10K | +179.8% |
| Net Income | -$26.6M | +29.4% |
| EPS (Basic) | -$0.73 | +86.4% |
| EPS (Diluted) | -$0.73 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.4M | +5345.1% |
| Current Assets | $70.8M | +507.9% |
| Total Assets | $72.8M | +509.4% |
| Current Liabilities | $4.3M | -68.8% |
| Total Liabilities | $4.6M | -67.2% |
| Stockholders' Equity | $68.2M | +3296.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.2M | -80.9% |
| Capital Expenditures | $1.6M | — |
| Investing Cash Flow | -$246K | -103.7% |
| Financing Cash Flow | $83.6M | +408.2% |
| Free Cash Flow | -$26.8M | -92.2% |
| +86.4% |